As of 2024-12-15, the Relative Valuation of Novacyt SA (ALNOV.PA) is (15.70) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.69 EUR, the upside of Novacyt SA based on Relative Valuation is -2388.0%.
The range of the Relative Valuation is (10.70) - (18.56) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.1x - 37.7x | 31.6x |
| Forward P/E multiples | 19.2x - 34.8x | 27.3x |
| Fair Price | (10.70) - (18.56) | (15.70) |
| Upside | -1660.0% - -2805.2% | -2388.0% |
| Date | P/E |
| 2024-12-10 | -1.16 |
| 2024-12-09 | -1.16 |
| 2024-12-06 | -1.20 |
| 2024-12-05 | -1.05 |
| 2024-12-04 | -1.06 |
| 2024-12-03 | -1.04 |
| 2024-12-02 | -1.04 |
| 2024-11-29 | -1.08 |
| 2024-11-28 | -1.08 |
| 2024-11-27 | -1.07 |
| 2024-11-26 | -1.08 |
| 2024-11-25 | -1.05 |
| 2024-11-22 | -1.08 |
| 2024-11-21 | -1.09 |
| 2024-11-20 | -1.09 |
| 2024-11-19 | -1.11 |
| 2024-11-18 | -1.14 |
| 2024-11-15 | -1.13 |
| 2024-11-14 | -1.17 |
| 2024-11-13 | -1.11 |
| 2024-11-12 | -1.14 |
| 2024-11-11 | -1.16 |
| 2024-11-08 | -1.18 |
| 2024-11-07 | -1.19 |
| 2024-11-06 | -1.21 |
| 2024-11-05 | -1.24 |
| 2024-11-04 | -1.21 |
| 2024-11-01 | -1.25 |
| 2024-10-31 | -1.23 |
| 2024-10-30 | -1.32 |
| 2024-10-29 | -1.17 |
| 2024-10-28 | -1.24 |
| 2024-10-25 | -1.27 |
| 2024-10-24 | -1.25 |
| 2024-10-23 | -1.29 |
| 2024-10-22 | -1.31 |
| 2024-10-21 | -1.24 |
| 2024-10-18 | -1.23 |
| 2024-10-17 | -1.26 |
| 2024-10-16 | -1.24 |
| 2024-10-15 | -1.30 |
| 2024-10-14 | -1.26 |
| 2024-10-11 | -1.26 |
| 2024-10-10 | -1.26 |
| 2024-10-09 | -1.31 |
| 2024-10-08 | -1.30 |
| 2024-10-07 | -1.40 |
| 2024-10-04 | -1.40 |
| 2024-10-03 | -1.38 |
| 2024-10-02 | -1.46 |